Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clyde W Yancy

Showing results (71-80 of 644) with videos related to

Pageof 65
Sort By:
JAMA Cardiology|April 27, 2022
Who Is at Risk for Heart Failure?Clyde W Yancy, Sadiya S Khan
JAMA Cardiology|September 23, 2016
Angiotensin Receptor Neprilysin Inhibitor Use Urgency: Festina LenteClyde W Yancy, Gregg C Fonarow
JAMA Cardiology|May 25, 2017
Claims Data to Ascertain Clinical Events: Lost in TranslationGregg C Fonarow, Clyde W Yancy
JAMA Cardiology|July 31, 2020
Coronavirus Disease 2019 (COVID-19) and the Heart-Is Heart Failure the Next Chapter?Clyde W Yancy, Gregg C Fonarow
JAMA|November 23, 2017
Consequences of Reductions in Hospital ReadmissionsGregg C Fonarow, Clyde W Yancy
JAMA Cardiology|July 6, 2022
Replacing Race With Social Determinants of Health in Risk Prediction-Getting It RightClyde W Yancy, Sadiya S Khan
JAMA Cardiology|April 24, 2024
Atrial Fibrillation Ablation in Heart Failure-More Data Are NeededKristen K Patton, Clyde W Yancy
Cardiology Clinics|April 17, 2017
Contemporary Approaches to Patients with Heart FailureSumeet S Mitter, Clyde W Yancy
Current Heart Failure Reports|July 23, 2005
Quality of care and outcomes in acute decompensated heart failure: The ADHERE RegistryClyde W Yancy, Gregg C Fonarow,
JACC. Heart Failure|May 13, 2019
Failure Is Not an Option: Optimizing Care for Heart Failure Patients at the End of LifeHaider J Warraich, Clyde W Yancy
Pageof 65

Showing results (71-80 of 644) with videos related to

Sort By:
Pageof 65
JAMA Cardiology|April 27, 2022
Who Is at Risk for Heart Failure?Clyde W Yancy, Sadiya S Khan
JAMA Cardiology|September 23, 2016
Angiotensin Receptor Neprilysin Inhibitor Use Urgency: Festina LenteClyde W Yancy, Gregg C Fonarow
JAMA Cardiology|May 25, 2017
Claims Data to Ascertain Clinical Events: Lost in TranslationGregg C Fonarow, Clyde W Yancy
JAMA Cardiology|July 31, 2020
Coronavirus Disease 2019 (COVID-19) and the Heart-Is Heart Failure the Next Chapter?Clyde W Yancy, Gregg C Fonarow
JAMA|November 23, 2017
Consequences of Reductions in Hospital ReadmissionsGregg C Fonarow, Clyde W Yancy
JAMA Cardiology|July 6, 2022
Replacing Race With Social Determinants of Health in Risk Prediction-Getting It RightClyde W Yancy, Sadiya S Khan
JAMA Cardiology|April 24, 2024
Atrial Fibrillation Ablation in Heart Failure-More Data Are NeededKristen K Patton, Clyde W Yancy
Cardiology Clinics|April 17, 2017
Contemporary Approaches to Patients with Heart FailureSumeet S Mitter, Clyde W Yancy
Current Heart Failure Reports|July 23, 2005
Quality of care and outcomes in acute decompensated heart failure: The ADHERE RegistryClyde W Yancy, Gregg C Fonarow,
JACC. Heart Failure|May 13, 2019
Failure Is Not an Option: Optimizing Care for Heart Failure Patients at the End of LifeHaider J Warraich, Clyde W Yancy
Pageof 65